The phase 3 program missed both primary and key secondary endpoints, with no statistically significant effects on relevant measures observed for patients receiving investigational treatment ...

With its vibrant red walls and white-trimmed corners, the Moonhouse will stand as a symbol of human ingenuity and the enduring connection between art and space exploration. As we await its successful ...

according to the final results of the Phase III KATHERINE clinical trial led by researchers from the University of Pittsburgh and UPMC Hillman Cancer Center. "KATHERINE is a landmark clinical ...

With dosing already underway, the next cohort in the Phase 1 study will provide additional insight into the development of this unprecedented approach to harnessing the power of FABP inhibition.